Dana Foss is CEO and a co-founder of Editpep.
View personal profileE
Editpep develops nonviral CRISPR delivery technology for potential therapies, initially focused on the brain.
Overview
Editpep develops a peptide-enabled system for delivering assembled CRISPR editing components into cells. Its initial therapeutic focus is the central nervous system.
The company says it holds an exclusive worldwide therapeutic license from UC Berkeley for its PERC platform and is advancing toward preclinical development. It also invites discussions about collaboration and licensing.
- Founded, company-reported
- 2023
- Location
- United States, California, Berkeley
Loading profile details…
Industries
- Industry category
- Healthcare & Life Sciences
- Specific industry
- Gene Editing Tool Developer
Classification sources and history
Gene Editing Tool Developer · Business involvement
As of 2026-11-08
Loading recent changes…
Sources & editorial review
(3)
Editorial profile by MoneyMakers. Sources reviewed .
